S. Stanisic, A. Bertolotto, P. Berto, P. Di Procolo, and J. Morawski, “The cost-effectiveness of alemtuzumab in the management of relapse-remitting multiple sclerosis in Italy”, Grhta, vol. 6, no. 1, Apr. 2019.